Whether BCG strains other than BCG TICE are safe and effective for treating high-grade NMIBC warrants rigorous testing.

Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or delivering the wrong diagnosis.

Data from the IMvigor011 phase 3 study shows that adjuvant atezolizumab (Tecentriq) significantly boosts the reduction and clearance of circulating tumor DNA (ctDNA). Presented at ...

The 2026 GU ASCO annual meeting featured a urothelial carcinoma session and a discussant presentation by Dr. Tyler F. Stewart ...

Protara Therapeutics has touted a 66% complete response (CR) rate for its cell therapy among certain bladder cancer patients ...

The actor James Van Der Beek, who died on Wednesday at 48, was among a growing number of adults under 50 diagnosed with the disease. By Nina Agrawal The actor James Van Der Beek died on Wednesday at ...

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending durvalumab (Imfinzi, AstraZeneca), given with gemcitabine and cisplatin before surgery and ...

Colorblindness, a condition that mostly affects men, could be linked to a higher mortality risk in bladder cancer cases, a new study suggests. About 8% of men are estimated to have a form of color ...

, Tongji University School of Medicine, Shanghai, China. 2Urologic Cancer Institute, Tongji University School of Medicine, Shanghai, China. , Tongji University School ...

Bladder cancer is one of the most prevalent malignant tumors of the urinary system worldwide, and its diagnosis and histopathological grading are crucial for clinical decision-making and prognostic ...